Caribou Biosciences
Caribou Biosciences Raises $304M in Series C
Quick Facts
Caribou Biosciences Raises $304M in Series C
Caribou Biosciences has successfully raised $304M in a Series C at a $1.2B valuation led by RA Capital Management, Baillie Gifford, Redmile Group, Pfizer Ventures.
Company Overview
Caribou Biosciences is a Biotech company headquartered in 2929 Seventh Street, Berkeley, CA 94710, founded in 2011 with 200+ employees.
CRISPR gene editing for cell therapies
Fundraising Details
- Amount Raised: $304M
- Round Type: Series C
- Valuation: $1.2B
- Date: 2024-03-17
- Investors: RA Capital Management, Baillie Gifford, Redmile Group, Pfizer Ventures
About Caribou Biosciences
CRISPR gene editing for cell therapies The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 2929 Seventh Street, Berkeley, CA 94710
- Founded: 2011
- Team Size: 200+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Caribou Biosciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Caribou Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $1.2B valuation marks an important milestone for Caribou Biosciences, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Caribou Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-03-17. For more information about Caribou Biosciences, visit their headquarters at 2929 Seventh Street, Berkeley, CA 94710.
About the Author
Related Company Reports
Anthropic Raises $2B in Series D
Anthropic, a AI/ML company based in San Francisco, CA, has raised $2B in Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.
xAI Raises $6B in Series C
xAI, a AI/ML company based in San Francisco, CA, has raised $6B in Series C at a $40B valuation led by Sequoia Capital, a16z, Valor Equity.
Adept AI Raises $350M in Series B
Adept AI, a AI/ML company based in San Francisco, CA, has raised $350M in Series B at a $1B valuation led by General Catalyst, Spark Capital, Addition.